Biotech Values

[DewDiligence]

LENZ—(+13%/AH)—receives FDA approval for 10-hour presbyopia eyedrop, Vizz:

https://www.globenewswire.com/news-release/2025/07/31/3125400/0/en/LENZ-Therapeutics-Announces-US-FDA-Approval-of-VIZZ-for-the-Treatment-of-Presbyopia.html

Vizz works by inducing pupil contraction—essentially the same technology as the box-like pinhole cameras of old. I don’t expect this to be a big-selling product.